Intraglomerular hypertension: Implications and drug treatment

Sharon Anderson, B. M. Brenner

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Systemic hypertension is both cause and consequence of progressive renal disease. Recent experimental studies indicate that systemic and glomerular capillary hypertension are not necessarily accompaniments, and that therapeutic interventions may affect systemic and glomerular pressures independently. Therapeutic interventions that control glomerular capillary hypertension protect against progressive renal injury, even in the presence of continued systemic hypertension. Conversely, therapy that controls systemic but not glomerular hypertension does not protect the kidney from continuing damage. Thus, control of intraglomerular hypertension is necessary if antihypertensive therapy is to be effective in preventing progression of renal injury.

Original languageEnglish (US)
Pages (from-to)243-253
Number of pages11
JournalAnnual Review of Medicine
Volume39
StatePublished - 1988
Externally publishedYes

Fingerprint

Drug therapy
Hypertension
Pharmaceutical Preparations
Kidney
Antihypertensive Agents
Wounds and Injuries
Therapeutics
Pressure

ASJC Scopus subject areas

  • Cell Biology
  • Medicine(all)

Cite this

Intraglomerular hypertension : Implications and drug treatment. / Anderson, Sharon; Brenner, B. M.

In: Annual Review of Medicine, Vol. 39, 1988, p. 243-253.

Research output: Contribution to journalArticle

@article{4de4397abd06446fba4004678db710db,
title = "Intraglomerular hypertension: Implications and drug treatment",
abstract = "Systemic hypertension is both cause and consequence of progressive renal disease. Recent experimental studies indicate that systemic and glomerular capillary hypertension are not necessarily accompaniments, and that therapeutic interventions may affect systemic and glomerular pressures independently. Therapeutic interventions that control glomerular capillary hypertension protect against progressive renal injury, even in the presence of continued systemic hypertension. Conversely, therapy that controls systemic but not glomerular hypertension does not protect the kidney from continuing damage. Thus, control of intraglomerular hypertension is necessary if antihypertensive therapy is to be effective in preventing progression of renal injury.",
author = "Sharon Anderson and Brenner, {B. M.}",
year = "1988",
language = "English (US)",
volume = "39",
pages = "243--253",
journal = "Annual Review of Medicine",
issn = "0066-4219",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Intraglomerular hypertension

T2 - Implications and drug treatment

AU - Anderson, Sharon

AU - Brenner, B. M.

PY - 1988

Y1 - 1988

N2 - Systemic hypertension is both cause and consequence of progressive renal disease. Recent experimental studies indicate that systemic and glomerular capillary hypertension are not necessarily accompaniments, and that therapeutic interventions may affect systemic and glomerular pressures independently. Therapeutic interventions that control glomerular capillary hypertension protect against progressive renal injury, even in the presence of continued systemic hypertension. Conversely, therapy that controls systemic but not glomerular hypertension does not protect the kidney from continuing damage. Thus, control of intraglomerular hypertension is necessary if antihypertensive therapy is to be effective in preventing progression of renal injury.

AB - Systemic hypertension is both cause and consequence of progressive renal disease. Recent experimental studies indicate that systemic and glomerular capillary hypertension are not necessarily accompaniments, and that therapeutic interventions may affect systemic and glomerular pressures independently. Therapeutic interventions that control glomerular capillary hypertension protect against progressive renal injury, even in the presence of continued systemic hypertension. Conversely, therapy that controls systemic but not glomerular hypertension does not protect the kidney from continuing damage. Thus, control of intraglomerular hypertension is necessary if antihypertensive therapy is to be effective in preventing progression of renal injury.

UR - http://www.scopus.com/inward/record.url?scp=0024217372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024217372&partnerID=8YFLogxK

M3 - Article

C2 - 3285775

AN - SCOPUS:0024217372

VL - 39

SP - 243

EP - 253

JO - Annual Review of Medicine

JF - Annual Review of Medicine

SN - 0066-4219

ER -